Growth inhibition and cytotoxicity induced by Bowman‐Birk inhibitor concentrate in cisplatin‐resistant human ovarian cancer cells

References

• Kennedy , AR . 1993 . “ Anticarcinogenic activity of protease inhibitors: overview ” . In Protease Inhibitors as Cancer Chemopreventive Agents , Edited by: Troll , W and Kennedy , AR . 9 – 64 . New York : Plenum .
   Google Scholar
• Kennedy , AR . 1993 . “ In vitro studies of anticarcinogenic protease inhibitors ” . In Protease Inhibitors as Cancer Chemopreventive Agents , Edited by: Troll , W and Kennedy , AR . 65 – 91 . New York : Plenum .
   Google Scholar
• Fontham , E and Correa , P . 1993 . “ The epidemiologic approach to the study of protease inhibitors ” . In Protease Inhibitors as Cancer Chemopreventive Agents , Edited by: Troll , W and Kennedy , AR . 1 – 8 . New York : Plenum .
   Google Scholar
• Messina , MJ , Persky , V , Setchell , KDR and Barnes , S . 1994 . Soy intake and cancer risk: a review of the in vitro and in vivo data . Nutr Cancer , 21 : 113 – 131 .
   PubMed Web of Science ®Google Scholar
• Kennedy , AR , Szuhaj , BF , Newbeme , PM and Billings , PC . 1993 . Preparation and production of a cancer chemopreventive agent, Bowman‐Birk inhibitor concentrate . Nutr Cancer , 19 : 281 – 302 .
   PubMed Web of Science ®Google Scholar
• Kennedy , AR , Beazer‐Barclay , Y , Kinzler , KW and Newbeme , PM . 1996 . Suppression of carcinogenesis in the intestines of mice by the soybean‐derived Bowman‐Birk inhibitor . Cancer Res , 56 : 679 – 682 .
   PubMed Web of Science ®Google Scholar
• Clark , DA , Day , R , Seidah , N , Moody , TW Cuttitta , F . 1993 . Protease inhibitors suppress in vitro growth of human small cell lung cancer . Peptides , 14 : 1021 – 1028 .
   PubMed Web of Science ®Google Scholar
• Kennedy , CW , Donahue , JJ and Wan , XS . 1996 . Effects of Bowman‐Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis‐platinum . Nutr Cancer , 26 : 209 – 217 .
   PubMed Web of Science ®Google Scholar
• Loehrer , PJ and Einhorn , LH . 1984 . Drugs five years later. Cisplatin . Ann Intern Med , 100 : 704 – 713 .
   PubMed Web of Science ®Google Scholar
• Ozols , RF and Young , RC . 1984 . Chemotherapy of ovarian cancer . Semin Oncol , 11 : 251 – 263 .
   PubMed Web of Science ®Google Scholar
• Kelley , SL and Rozencweig , M . 1989 . Resistance to platinum compounds: mechanisms and beyond . Eur J Cancer Clin Oncol , 25 : 1135 – 1140 .
   PubMedGoogle Scholar
• Andrews , PA and Howell , SB . 1990 . Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance . Cancer Cells , 2 : 35 – 43 .
   PubMed Web of Science ®Google Scholar
• Chao , CC . 1996 . Molecular basis of cu‐diamminedichloroplatinum (II) resistance: a review . J Formos MedAssoc , 95 : 893 – 900 .
   PubMed Web of Science ®Google Scholar
• Yang , X and Page , M . 1995 . P‐glycoprotein expression in ovarian cancer cell line following treatment with cisplatin . Oncol Res , 7 : 619 – 624 .
   PubMed Web of Science ®Google Scholar
• Singh , SV , Xu , BH , Jani , JP , Emerson , EO Backes , MG . 1995 . Mechanism of cross‐resistance to cisplatin in a mitomycin C‐resistant human bladder cancer cell line . Int J Cancer , 61 : 431 – 436 .
   PubMed Web of Science ®Google Scholar
• Basu , A and Weixel , KM . 1995 . Comparison of protein kinase C activity and isoform expression in cisplatin‐sensitive and ‐resistant ovarian carcinoma cells . Int J Cancer , 62 : 457 – 460 .
   PubMed Web of Science ®Google Scholar
• Johnson , SW , Swiggard , PA , Handel , LM , Brennan , JM Godwin , AK . 1994 . Relationship between platinum‐DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin‐sensitive and ‐resistant human ovarian cancer cells . Cancer Res , 54 : 5911 – 5916 .
   PubMedGoogle Scholar
• Zamble , DB and Lippard , SJ . 1995 . Cisplatin and DNA repair in cancer chemotherapy . Trends Biochem Sci , 20 : 435 – 439 .
   PubMed Web of Science ®Google Scholar
• Johnson , SW , Laub , PB , Beesley , JS , Ozols , RF and Hamilton , TO . 1997 . Increased platinum‐DNA damage tolerance is associated with cisplatin resistance and cross‐resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines . Cancer Res , 57 : 850 – 856 .
   PubMed Web of Science ®Google Scholar
• Gosland , M , Lum , B , Schimmelpfennig , J , Baker , J and Doukas , M . 1996 . Insights into mechanisms of cisplatin resistance and potential for its clinical reversal . Pharmacotherapy , 16 : 16 – 39 .
   PubMed Web of Science ®Google Scholar
• Arvelo , F , Poupon , MF , Bichat , F , Grossin , F Bourgeois , Y . 1995 . Adding a reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenografts . Eur J Cancer , 31A : 1862 – 1868 .
   PubMedGoogle Scholar
• Jekunen , A , Vick , J , Sanga , R , Chan , TC and Howell , SB . 1992 . Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro . Cancer Res , 52 : 3566 – 3571 .
   PubMed Web of Science ®Google Scholar
• Alaoui‐Jamali , M , Loubaba , BB , Robyn , S , Tapiero , H and Batist , G . 1994 . Effect of DNA‐repair‐enzyme modulators on cytotoxicity of L‐phenyl‐alanine mustard and cis‐diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs . Cancer Chemother Pharmacol , 34 : 153 – 158 .
   PubMedGoogle Scholar
• Kelland , LR and Steel , GG . 1988 . Modification of radiation dose‐rate sparing effects in a human carcinoma of the cervix cell line by inhibitors of DNA repair . Int J Radiat Biol , 54 : 229 – 244 .
   PubMed Web of Science ®Google Scholar
• Andrews , PA , Schiefer , MA , Murphy , MP and Howell , SB . 1988 . Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletion . Chemicobiol Interact , 65 : 51 – 58 .
   PubMed Web of Science ®Google Scholar
• Pu , YS , Hsieh , TS , Tsai , TC , Cheng , AL Hsieh , CY . 1995 . Tamoxifen enhances the chemosensitivity of bladder carcinoma cells . J Urol , 154 : 601 – 605 .
   PubMedGoogle Scholar
• Kondo , S , Yin , D , Morimura , T and Takeuchi , J . 1995 . Combination therapy with cisplatin and nifedipine inducing apoptosis in multidrug‐resistant human glioblastoma cells . J Neurosurg , 82 : 469 – 474 .
   PubMed Web of Science ®Google Scholar
• Ercoli , A , Scambia , G , De Vincenzo , R , Alimonti , A Petrucci , F . 1996 . Tamoxifen synergizes the antiproliferative effect of cisplatin in human ovarian cancer cells: enhancement of DNA platination as a possible mechanism . Cancer Lett , 108 : 7 – 14 .
   PubMed Web of Science ®Google Scholar
• Yao , K‐S , Godwin , AK , Johnson , SW , Ozols , RF O'Dwyer , PJ . 1995 . Evidence for altered regulation of γ‐glutamylcysteine synthetase gene expression among cisplatin‐sensitive and cisplatin‐resistant human ovarian cancer cell lines . Cancer Res , 55 : 4367 – 4374 .
   PubMed Web of Science ®Google Scholar
• Kennedy , AR . 1995 . The evidence for soybean products as cancer preventive agents . J Nutr , 125 : 733s – 743s .
   PubMed Web of Science ®Google Scholar
• Sung , MK , Kendall , CW , Koo , MM and Rao , AV . 1995 . Effect of soybean saponins and Gypsophilla saponin on growth and viability of colon carcinoma cells in culture . Nutr Cancer , 23 : 259 – 270 .
   PubMed Web of Science ®Google Scholar
• Rao , AV and Sung , MK . 1995 . Saponins as anticarcinogens . J Nutr , 125 : 717S – 724S .
   PubMed Web of Science ®Google Scholar
• Constantinou , Al , Mehta , RG and Vaughan , A . 1996 . Inhibition of N‐methyl‐N‐nitrosourea‐induced mammary tumors in rats by the soybean isoflavones . Anticancer Res , 16 : 3293 – 3298 .
   PubMed Web of Science ®Google Scholar
• Bhushan , A , Abramson , R , Chiu , JF and Tritton , TR . 1992 . Expression of c‐fos in human and murine multidrug‐resistant cells . Mol Pharmacol , 42 : 69 – 74 .
   PubMed Web of Science ®Google Scholar
• Kashani‐Sabet , M , Wang , W and Scanlon , KJ . 1990 . Cyclosporin A suppresses cisplatin‐induced c‐fos gene expression in ovarian carcinoma cells . J Biol Chem , 265 : 11285 – 11288 .
   PubMed Web of Science ®Google Scholar
• Johnson , BE , Ihde , DC , Makuch , RW , Gazdar , AF Carney , DN . 1987 . myc Family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course . J Clin Invest , 79 : 1629 – 1634 .
   PubMed Web of Science ®Google Scholar
• Brennan , J , O'Connor , T , Makuch , RW , Simmons , AM Russell , E . 1991 . myc Family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens . Cancer Res , 51 : 1708 – 1712 .
   PubMed Web of Science ®Google Scholar
• Mizutani , Y , Fukumoto , M , Bonavida , B and Yoshida , O . 1994 . Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c‐myc antisense oligonucleotide . Cancer , 74 : 2546 – 2554 .
   PubMed Web of Science ®Google Scholar
• Caggana , M and Kennedy , AR . 1989 . c‐fos mRNA levels are reduced in the presence of antipain and Bowman‐Birk inhibitor . Carcinogenesis , 10 : 2145 – 2148 .
   PubMed Web of Science ®Google Scholar
• St. Clair , WH and St. Clair , DK . 1991 . Effect of the Bowman‐Birk protease inhibitor on the expression of oncogenes in the irradiated rat colon . Cancer Res , 51 : 4539 – 4543 .
   PubMed Web of Science ®Google Scholar
• Chang , JD , Li , J‐H , Billings , PC and Kennedy , AR . 1990 . Effects of protease inhibitors on c‐myc expression in normal and transformed C3H 101/2 cell lines . Mol Carcinog , 3 : 226 – 232 .
   PubMed Web of Science ®Google Scholar
• Chang , JD and Kennedy , AR . 1993 . “ Suppression of c‐myc by anticarcino‐genic protease inhibitors ” . In Protease Inhibitors as Cancer Chemopreventive Agents , Edited by: Troll , W and Kennedy , AR . 265 – 280 . New York : Plenum .
   Google Scholar
• St. Clair , WH , Billings , PC and Kennedy , AR . 1990 . The effects of the Bowman‐Birk protease inhibitor on c‐myc expression and cell proliferation in the unirradiated and irradiated mouse colon . Cancer Lett , 52 : 145 – 152 .
   PubMed Web of Science ®Google Scholar
• Yu , H , Levesque , MA , Khosravi , MJ , Papanastasiou‐Diamandi , A Clark , GM . 1996 . Associations between insulin‐like growth factors and their binding proteins and other prognostic indicators in breast cancer . Br J Cancer , 74 : 1242 – 1247 .
   PubMed Web of Science ®Google Scholar
• Yamashita , J , Ogawa , M , Yamashita , S , Nakashima , Y Saishoji , T . 1993 . Differential biological significance of tissue‐type and urokinasetype plasminogen activator in human breast cancer . Br J Cancer , 68 : 524 – 529 .
   PubMed Web of Science ®Google Scholar
• Claudio , E , Segade , F , Wrobel , K , Ramos , S Bravo , R . 1996 . Molecular mechanisms of TNF‐α cytotoxicity: activation of NF‐κ? and nuclear translocation . Exp Cell Res , 224 : 63 – 71 .
   PubMed Web of Science ®Google Scholar
• Benitez‐Bribiesca , L , Martinez , G , Ruiz , MT , Gutierrez‐Delgado , F and Utrera , D . 1995 . Proteinase activity in invasive cancer of the breast. Correlation with tumor progression . Arch Med Res , 26 : S163 – S168 .
   PubMedGoogle Scholar